Roche Holding AG-Genusschein
13F holders, Q3 2025 (September 30)4holders +1
1new positions
0sold out
$326.65avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Roche Holding AG-Genusschein in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Aristotle Capital Management, LLC ($72.3M), Boston Common Asset Management, LLC ($28.3M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.2M).
- Company
- Roche Holding AG-Genusschein
- CUSIP
- H69293217
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $170K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 12,986 shares bought and 16,926 shares sold, net −3,940 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Aristotle Capital Management, LLC | 0.14% | Reduce -6.8% | 221,238 | $72.3M |
| Boston Common Asset Management, LLC | 0.79% | Add +16.8% | 86,719 | $28.3M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.16% | Reduce -10.3% | 6,638 | $2.2M |
| Saranac Partners Ltd | 0.04% | New | 520 | $170K |
"% of holder's portfolio" is ROCHE HOLDING AG-GENUSSCHEIN's weight in each manager's 13F, not the share of Roche Holding AG-Genusschein the manager owns.